COVID-19 Clinical Trials

A listing of COVID-19 medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 154 clinical trials
featured
COVID-19 Treatment Trial: Investigational Medication as a Non-antiviral Immunomodulator

The study is designed to compare two COVID-19 treatment regimens in hospitalized adult subjects who are diagnosed with severe COVID 19.  The investigational medication is called CD24Fc

  • 3989 views
  • 17 Jun, 2020
  • 4 locations
featured
  • 198 views
  • 23 Nov, 2020
  • 1 location
featured
COMMANDS - Myelodysplastic Syndromes (MDS) - ACE536-MDS-002 - US  

The study will be conducted in compliance with the International Council for Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use/Good Clinical Practice (GCP) and applicable regulatory requirements.   This is an interventional active-controlled, open-label, randomized Phase 3 study to compare the efficacy and safety of luspatercept …

vasectomy
epoetin alfa
cancer
erythropoietin
  • 5134 views
  • 25 May, 2021
  • 14 locations
Immune Modulators for Treating COVID-19

. Comparisons of the agents among themselves is not a research objective. The study population corresponds to moderately and severely ill patients infected with the coronavirus disease 2019 (COVID-19

  • 0 views
  • 16 Jun, 2021
  • 82 locations
The Prevent Severe COVID-19 (PRESECO) Study

Double-blinded, placebo control, randomized, phase-3 clinical trial to evaluate clinical efficacy of Favipiravir in patients with mild to moderate symptoms related to COVID-19 infection

  • 0 views
  • 01 Apr, 2021
  • 24 locations
ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19

This study looks at the safety and effectiveness of different drugs in treating COVID-19 in people who have been hospitalized with the infection and who have acute respiratory failure

  • 0 views
  • 16 Jun, 2021
  • 23 locations
UPMC OPTIMISE-C19 Trial a COVID-19 Study

Multiple monoclonal antibodies (mABs) have been shown to reduce viral burden and improve clinical outcomes, have been granted FDA Emergency Use Authorization (EUA) for use in select populations, and are routinely used in the UPMC Health System, which has made expanded access a priority. However, the comparative effectiveness of these …

  • 0 views
  • 15 May, 2021
  • 1 location
COVID-19 Thrombosis Prevention Trials: Post-hospital Thromboprophylaxis

A multicenter, adaptive, randomized platform trial evaluating the efficacy and safety of antithrombotic strategies in patients with COVID-19 following hospital discharge

  • 0 views
  • 03 Jun, 2021
  • 53 locations
ACTIV-6: COVID-19 Study of Repurposed Medications

The purpose of this study is to evaluate the effectiveness of repurposed medications (study drug(s) in reducing symptoms of non-hospitalized participants with mild to moderate COVID-19

  • 0 views
  • 16 Jun, 2021
  • 2 locations
Trial to Determine the Efficacy/Safety of Plitidepsin vs Control in Patients With Moderate COVID-19 Infection

Treatment of patients hospitalised for management of moderate COVID-19 infection

  • 0 views
  • 19 Jun, 2021
  • 31 locations